THW

Tekla World Healthcare Fund [THW] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

THW Stock Summary

Top THW Correlated Resources

THW


Top 10 Correlated ETFs

THW


Top 10 Correlated Stocks

THW


In the News

06:08 29 Mar 2024 THW

THW And THQ: Global Healthcare Exposure With A Double-Digit Yield

abrdn World Healthcare Fund provides exposure to top-tier healthcare holdings with a high distribution yield of over 10.7%. THW has a global focus with over 40% of their portfolio having exposure to companies based outside the U.S. or companies that get a large percentage of their revenue internationally.

10:30 29 Mar 2024 THW

Yes, You Can Retire On Dividends, 2 Fat Yields Up To 10%

The market's biggest secret is that you don't need to own a market-wide ETF to succeed. You don't need to sell your assets to fund your retirement. Reject that. Your retirement needs income; let the market pay your way.

08:30 29 Mar 2024 THW

Two +8% Yields To Buy And Never Let Go

The stock market is an incredible wealth builder for those with patience and long-term focus. We collect dividends through the seesaw and amplify our income through the art of compounding. Two monthly-pay closed-end funds to strengthen your financial flexibility in retirement – UTG and THW.

02:16 29 Mar 2024 THW

BME Vs. THW: A Distribution Cut Should Widen The Performance Gap

We had contrasting outlooks on the BlackRock Health Sciences Trust and abrdn World Healthcare Fund closed-end funds on our last coverage, with BME getting a "Buy" and THW getting a "Goodbye". BME has outperformed THW by 10% in total returns since then. We update our outlook and explain why one of these two gets a downgrade.

11:37 29 Mar 2024 THW

Weekly Closed-End Fund Roundup: November 26, 2023

19 out of 22 CEF sectors are positive on price, and 21 out of 22 sectors are positive on NAV. KYN/KMF merger completes. NXG Cushing Midstream Energy Fund rights offering begins.

11:22 29 Mar 2024 THW

Weekly Closed-End Fund Roundup: Tortoise Tender Results (November 19, 2023)

22 out of 22 CEF sectors positive on price and 21 out of 22 sectors positive on NAV. Tortoise tender offering results. Eaton Vance tender offer results.

09:30 29 Mar 2024 THW

5 Best CEFs This Month For 10% Yield (November 2023)

For income investors, closed-end funds remain an attractive investment class that covers a variety of asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs, are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone. In this monthly series, we highlight five CEFs with solid track records that pay high distributions and offer "excess" discounts. We try to separate the wheat from the chaff using our filtering process to select just five CEFs every month from around 500 closed-end funds.

03:17 29 Mar 2024 THW

THW: abrdn Takes Over, Fund Drops To Massive Discount, But THQ Still Looking Better

abrdn has taken over the management of the former Tekla funds, and they've dropped to some meaningful discounts. Both the abrdn World Healthcare Fund and the abrdn Healthcare Opportunities Fund represent attractive investment opportunities, but I would tend to favor THQ. THW has a higher distribution rate when compared to THQ, which can have some appeal for some investors, but both funds will rely entirely on capital gains going forward.

09:00 29 Mar 2024 THW

5 Best CEFs This Month For 10% Yield (October 2023)

For income investors, closed-end funds remain an attractive investment class that covers a variety of asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs, are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone. In this monthly series, we highlight five CEFs with solid track records, pay high distributions, and offer "excess" discounts. We try to separate the wheat from the chaff using our filtering process to select just five CEFs every month from around 500 closed-end funds.

05:03 29 Mar 2024 THW

ASGI Vs. UTF: Battle Of The High Yielders

ASGI Vs. UTF: Battle Of The High Yielders

THW Financial details

Company Rating
Sell
Market Cap
492.46M
Income
-25.22M
Revenue
84.07M
Book val./share
11.73
Cash/share
0.52
Dividend
1.4
Dividend %
11.52%
Employees
-
Optionable
No
Shortable
Yes
Earnings
14 Nov 2018
P/E
0
Forward P/E
-
PEG
-
P/S
11.83
P/B
-
P/C
25.44
P/FCF
10.29
Quick Ratio
1.66
Current Ratio
1.66
Debt / Equity
0.54
LT Debt / Equity
0.27
-
-
EPS (TTM)
-0.69
EPS next Y
-
EPS next Q
1.58
EPS this Y
-147.37%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
NAN%
Revenue Q/Q
2144.58%
EPS Q/Q
-117.5%
-
-
-
-
SMA20
-
SMA50
-
SMA100
30%
Inst Own
13.33%
Inst Trans
1%
ROA
7%
ROE
8%
ROC
0.07%
Gross Margin
100%
Oper. Margin
96%
Profit Margin
96%
Payout
130%
Shs Outstand
38M
Shs Float
38M
-
-
-
-
Target Price
-
52W Range
9.76-14.89
52W High
-5.5%
52W Low
+47%
RSI
66
Rel Volume
0.72
Avg Volume
152.06K
Volume
109.84K
Perf Week
1.93%
Perf Month
4.5%
Perf Quarter
13.17%
Perf Half Y
11.08%
-
-
-
-
Beta
0.883278
-
-
Volatility
0.13%, 0.21%
Prev Close
0%
Price
13.23
Change
-0.15%

THW Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-09-30

Metric History 2019-09-302020-09-302021-09-302022-09-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
-0.312.072.48-2.041.02
Net income per share
-0.352.032.44-2.090.99
Operating cash flow per share
0.671.27-1.591.621.18
Free cash flow per share
0.671.27-1.591.621.18
Cash per share
0.240.40.990.620.52
Book value per share
13.5114.2216.2115.1411.73
Tangible book value per share
13.5114.2216.2115.1411.73
Share holders equity per share
13.5114.2216.2115.1411.73
Interest debt per share
8.098.086.918.076.48
Market cap
405.3M429.92M573.95M385.82M446.69M
Enterprise value
525.3M548.55M693.95M505.82M566.69M
P/E ratio
-37.997.066.74-6.1411.87
Price to sales ratio
-43.056.926.63-6.311.45
POCF ratio
19.9411.26-10.377.969.96
PFCF ratio
19.9411.26-10.377.969.96
P/B Ratio
0.991.011.010.851
PTB ratio
0.991.011.010.851
EV to sales
-55.88.838.02-8.2614.53
Enterprise value over EBITDA
-49.249.018.15-8.3215.06
EV to operating cash flow
25.8514.37-12.5410.4412.64
EV to free cash flow
25.8514.37-12.5410.4412.64
Earnings yield
-0.030.140.15-0.160.08
Free cash flow yield
0.050.09-0.10.130.1
Debt to equity
0.590.560.420.530.54
Debt to assets
0.450.440.340.410.42
Net debt to EBITDA
-11.251.951.41-1.973.19
Current ratio
1.2711.560.124.081.66
Interest coverage
-2.7224.5174.66-29.725.38
Income quality
-1.90.63-0.65-0.771.19
Dividend Yield
0.10.10.080.130.11
Payout ratio
-3.970.680.53-0.771.3
Sales general and administrative to revenue
-0.10.020.01-0.020.03
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
10.3725.4829.8326.7116.14
ROIC
-0.020.090.11-0.090.05
Return on tangible assets
-0.020.110.12-0.110.07
Graham Net
-3.54-3.59-2.67-3.23-2.35
Working capital
502.28K2.26M-19.6M2.33M1.04M
Tangible asset value
407.47M426.53M565.68M454.34M447.12M
Net current asset value
-120.68M-119.12M-145.73M-125.5M-120M
Invested capital
0.590.560.420.530.54
Average receivables
27.1M2.41M2.62M2.93M2.85M
Average payables
19.53M1.03M11.29M11.56M1.17M
Average inventory
55.17M7.37M18.7M29.55M22.09M
Days sales outstanding
-90.6614.5411.66-18.3924.55
Days payables outstanding
107.5812.351.15K36.7184.31
Days of inventory on hand
862.8201.93K1.05K1.2K
Receivables turnover
-4.0325.131.3-19.8414.87
Payables turnover
3.3929.550.329.944.33
Inventory turnover
0.4200.190.350.31
ROE
-0.030.140.15-0.140.08
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q4

Metric History 2021-09-302022-03-312022-09-302023-03-31 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.470.180.840.051.16
Net income per share
1.010.28-1.961.2-0.21
Operating cash flow per share
0.030.040.030.01-0.12
Free cash flow per share
0.030.040.030.01-0.12
Cash per share
0.930.460.50.330.52
Book value per share
15.1814.7712.1212.6411.73
Tangible book value per share
15.1814.7712.1212.6411.73
Share holders equity per share
15.1814.7712.1212.6411.73
Interest debt per share
6.466.446.446.416.4
Market cap
612.84M569.3M482.25M521.37M446.69M
Enterprise value
732.84M689.3M602.25M641.36M566.69M
P/E ratio
4.0713.37-1.642.85-13.87
Price to sales ratio
11.286.0415.33265.8310.15
POCF ratio
491.33380.71378.432.73K-97.38
PFCF ratio
491.33380.71378.432.73K-97.38
P/B Ratio
1.081.031.061.091
PTB ratio
1.081.031.061.091
EV to sales
13.39104.1819.14327.0112.87
Enterprise value over EBITDA
19.1660.89-8.3613.15-135.46
EV to operating cash flow
587.54460.96472.63.36K-123.54
EV to free cash flow
587.54460.96472.63.36K-123.54
Earnings yield
0.060.02-0.150.09-0.02
Free cash flow yield
0000-0.01
Debt to equity
0.420.430.530.50.54
Debt to assets
0.340.350.410.40.42
Net debt to EBITDA
3.1410.6-1.672.46-28.68
Current ratio
0.1218.54.082.371.66
Interest coverage
67.3216.79-52.5515.62-1.08
Income quality
0.030.14-0.0200.57
Dividend Yield
0.040.040.050.050.05
Payout ratio
0.662.28-0.330.53-3.04
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
18.599.7323.1118.57.47
ROIC
0.050.01-0.10.07-0.01
Return on tangible assets
0.050.02-0.130.08-0.01
Graham Net
-2.5-2.54-2.58-2.77-2.35
Working capital
-19.6M5.37M2.33M1.71M1.04M
Tangible asset value
565.68M552.09M454.34M479.62M447.12M
Net current asset value
-145.73M-121.73M-125.5M-124.59M-120M
Invested capital
0.420.430.530.50.54
Average receivables
2.66M4.22M4.38M3.02M2.79M
Average payables
11.28M11.34M531.78K1.01M1.42M
Average inventory
27.67M30.06M22.2M18.59M19M
Days sales outstanding
4.5577.298.83135.735.36
Days payables outstanding
514.17.318.2332.9841.47
Days of inventory on hand
859.87539.92522.47407.58588.56
Receivables turnover
19.81.1610.20.6616.78
Payables turnover
0.1812.334.942.732.17
Inventory turnover
0.10.170.170.220.15
ROE
0.070.02-0.160.1-0.02
Capex per share
00000

THW Frequently Asked Questions

What is Tekla World Healthcare Fund stock symbol ?

Tekla World Healthcare Fund is a US stock , located in Boston of Ma and trading under the symbol THW

What is Tekla World Healthcare Fund stock quote today ?

Tekla World Healthcare Fund stock price is $13.23 today.

Is Tekla World Healthcare Fund stock public?

Yes, Tekla World Healthcare Fund is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap